JP2016516985A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016516985A5 JP2016516985A5 JP2015562256A JP2015562256A JP2016516985A5 JP 2016516985 A5 JP2016516985 A5 JP 2016516985A5 JP 2015562256 A JP2015562256 A JP 2015562256A JP 2015562256 A JP2015562256 A JP 2015562256A JP 2016516985 A5 JP2016516985 A5 JP 2016516985A5
- Authority
- JP
- Japan
- Prior art keywords
- abnormalities
- pharmaceutical composition
- stem cells
- human subject
- mesenchymal stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13382091 | 2013-03-15 | ||
| EP13382091.0 | 2013-03-15 | ||
| PCT/EP2014/055282 WO2014140362A2 (en) | 2013-03-15 | 2014-03-17 | Lymphocyte biomarkers for determining the clinical response to cell therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019140842A Division JP6883070B2 (ja) | 2013-03-15 | 2019-07-31 | 細胞治療に対する臨床反応を決定するためのリンパ球バイオマーカー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016516985A JP2016516985A (ja) | 2016-06-09 |
| JP2016516985A5 true JP2016516985A5 (https=) | 2017-04-27 |
| JP6567430B2 JP6567430B2 (ja) | 2019-08-28 |
Family
ID=48044710
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015562256A Active JP6567430B2 (ja) | 2013-03-15 | 2014-03-17 | 細胞治療に対する臨床反応を決定するためのリンパ球バイオマーカー |
| JP2019140842A Expired - Fee Related JP6883070B2 (ja) | 2013-03-15 | 2019-07-31 | 細胞治療に対する臨床反応を決定するためのリンパ球バイオマーカー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019140842A Expired - Fee Related JP6883070B2 (ja) | 2013-03-15 | 2019-07-31 | 細胞治療に対する臨床反応を決定するためのリンパ球バイオマーカー |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10660920B2 (https=) |
| EP (2) | EP3581932A1 (https=) |
| JP (2) | JP6567430B2 (https=) |
| AU (2) | AU2014230014B2 (https=) |
| CA (2) | CA3188652A1 (https=) |
| DK (1) | DK2972368T3 (https=) |
| ES (1) | ES2748825T3 (https=) |
| HU (1) | HUE046531T2 (https=) |
| IL (1) | IL241586B (https=) |
| PL (1) | PL2972368T3 (https=) |
| PT (1) | PT2972368T (https=) |
| SG (1) | SG11201507521UA (https=) |
| WO (1) | WO2014140362A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060045872A1 (en) | 2004-08-25 | 2006-03-02 | Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco | Use of adipose tissue-derived stromal stem cells in treating fistula |
| KR101536239B1 (ko) | 2005-09-23 | 2015-07-13 | 셀레릭스, 에스.엘. | 면역조절활성을 갖는 세포 개체군, 분리 방법 및 용도 |
| US10660920B2 (en) | 2013-03-15 | 2020-05-26 | Tigenix Nv | Lymphocyte biomarkers for determining the clinical response to cell therapy |
| US10746729B2 (en) | 2015-04-24 | 2020-08-18 | Tigenix, S.A.U. | Biomarkers for determining the clinical response to cell therapy |
| GB201604304D0 (en) * | 2016-03-14 | 2016-04-27 | Tigenix S A U | Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease |
| JP7276664B2 (ja) | 2016-11-11 | 2023-05-18 | ロングエバーオン インコーポレイテッド | 細胞性及び体液性免疫を達成するためのヒト間葉系幹細胞を使用する方法 |
| JP7628499B2 (ja) * | 2019-02-27 | 2025-02-10 | 武田薬品工業株式会社 | 同種異系療法のための改良された幹細胞集団 |
| US20240000850A1 (en) * | 2020-04-08 | 2024-01-04 | Figene, Llc | Methods and compositions for allergy and asthma treatment using fibroblasts |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001028581A1 (fr) * | 1999-10-20 | 2001-04-26 | Chugai Seiyaku Kabushiki Kaisha | Compositions medicinales pouvant inhiber gvhd |
| EP3461884B1 (en) * | 2004-03-22 | 2025-05-28 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
| EP1871419A4 (en) * | 2005-04-22 | 2009-01-14 | Univ Maryland | METHODS OF TREATING REJECTION OF GRAFT AGAINST HOST |
| CA2832356C (en) * | 2011-04-06 | 2017-12-19 | Sanbio, Inc. | Methods and compositions for modulating peripheral immune function |
| US10660920B2 (en) | 2013-03-15 | 2020-05-26 | Tigenix Nv | Lymphocyte biomarkers for determining the clinical response to cell therapy |
-
2014
- 2014-03-17 US US14/776,233 patent/US10660920B2/en active Active
- 2014-03-17 JP JP2015562256A patent/JP6567430B2/ja active Active
- 2014-03-17 WO PCT/EP2014/055282 patent/WO2014140362A2/en not_active Ceased
- 2014-03-17 HU HUE14712628A patent/HUE046531T2/hu unknown
- 2014-03-17 AU AU2014230014A patent/AU2014230014B2/en active Active
- 2014-03-17 PT PT147126288T patent/PT2972368T/pt unknown
- 2014-03-17 CA CA3188652A patent/CA3188652A1/en active Pending
- 2014-03-17 EP EP19187915.4A patent/EP3581932A1/en not_active Withdrawn
- 2014-03-17 PL PL14712628T patent/PL2972368T3/pl unknown
- 2014-03-17 SG SG11201507521UA patent/SG11201507521UA/en unknown
- 2014-03-17 DK DK14712628.8T patent/DK2972368T3/da active
- 2014-03-17 CA CA2906299A patent/CA2906299C/en active Active
- 2014-03-17 ES ES14712628T patent/ES2748825T3/es active Active
- 2014-03-17 EP EP14712628.8A patent/EP2972368B1/en active Active
-
2015
- 2015-09-16 IL IL241586A patent/IL241586B/en active IP Right Grant
-
2019
- 2019-07-31 JP JP2019140842A patent/JP6883070B2/ja not_active Expired - Fee Related
-
2020
- 2020-02-05 AU AU2020200807A patent/AU2020200807B2/en active Active
- 2020-04-21 US US16/854,294 patent/US11478511B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016516985A5 (https=) | ||
| JP2015131795A5 (https=) | ||
| GB2569921A (en) | Bisymmetric comparison of sub-epidermal moisture values | |
| WO2019006005A3 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MELANOMA | |
| Niknejad et al. | Anticancer effects of human amniotic membrane and its epithelial cells | |
| EA201270803A1 (ru) | Тиоацетатные соединения, композиции на их основе и способы их применения | |
| EP4652923A3 (en) | Apparatus for determining damaged tissue using sub-epidermal moisture measurements | |
| EA202190722A1 (ru) | Клинические композиции | |
| EA201691516A1 (ru) | Дигидропирролопиридиновые ингибиторы ror-гамма | |
| WO2017062456A3 (en) | Biomarkers related to interleukin-33 (il-33)-mediated diseases and uses thereof | |
| WO2015148389A3 (en) | Diagnosis of multiple sclerosis in human and animal subjects | |
| MA52644A (fr) | Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation | |
| EP4252742A3 (en) | Fluticasone furoate in the treatment of copd | |
| BR112017001971A2 (pt) | ?métodos e composições para diagnosticar e tratar distúrbios inflamatórios intestinais? | |
| JP2012518646A5 (https=) | ||
| PH12017502099B1 (en) | Methods for diagnosing and assessing treatment for cushing's syndrome | |
| BR112016028561A2 (pt) | composição, forma de dosagem, e, métodos para reduzir o risco para mortalidade em um indivíduo, o risco para uma doença ou condição em um indivíduo, triglicerídeos em um sangue de indivíduo, a frequência cardíaca em repouso de um indivíduo, o colesterol de lipoproteína de densidade não alta em um indivíduo, o colesterol total em um indivíduo, a apolipoproteína b em um sangue de indivíduo, pressão sanguínea sistólica em um indivíduo e a pressão sanguínea diastólica em um indivíduo, para prolongar a vida de um indivíduo, para tratar hipertrigliceridemia em um indivíduo e para aumentar um índice de ômega-3 em células vermelhas do sangue de um indivíduo. | |
| WO2015120436A3 (en) | Stat3 phosphorylation during graft-versus-host disease | |
| EP4356967A3 (en) | Compounds for use as imaging agents | |
| ME03295B (me) | Inhibitor transfer proteina holesteril estra (cetp) i farmaceutske kompozicije koje sadrže pomenuti inhibitor za upotrebu u tretmanu ili prevenciji kardiovaskularnih bolesтi | |
| WO2016081733A3 (en) | Compositions and methods for modulating at2r activity | |
| WO2019055776A3 (en) | Compositions and methods for treatment of diseases involving cxcl1 function | |
| Chastek et al. | C31 CLINICAL ASTHMA I: The Few Who Use The Most: Costs Of Severe And Persistent Asthma In A Us Managed Care Plan | |
| WO2015168607A3 (en) | Ceacam5 peptides for crohn's disease | |
| EP4328245A3 (en) | Antibodies for use in treating conditions related to specific pcsk9 variants in specific patients populations |